Breast cancer: Test means fewer women will need chemotherapy-3
'Fundamental change' The study, led by the Albert Einstein
Cancer Center in New York, is a rare
cancer breakthrough as it can save
money and instantly change practice. Dr Alistair Ring, a consultant at the
Royal Marsden Hospital in London,
told the BBC: "Oncologists have been
waiting for these results, it will affect
practice on Monday morning. "It's a fundamental change in the way
we look after women with early breast
cancer. "It's a great news story." He estimates 3,000 women a year in
the UK will no longer need
chemotherapy because of this trial. The study is strictly about early stage
breast cancers - specifically those
that can still be treated with hormone
therapy, have not spread to the lymph
nodes and do not have the HER2
mutation, which makes them grow more quickly. The test is performed on
a sample of
the tumour when it is removed during
surgery. It works by looking at the activity
levels of 21 genes, which are markers
of how aggressive the cancer is.-BBC News
Cancer Center in New York, is a rare
cancer breakthrough as it can save
money and instantly change practice. Dr Alistair Ring, a consultant at the
Royal Marsden Hospital in London,
told the BBC: "Oncologists have been
waiting for these results, it will affect
practice on Monday morning. "It's a fundamental change in the way
we look after women with early breast
cancer. "It's a great news story." He estimates 3,000 women a year in
the UK will no longer need
chemotherapy because of this trial. The study is strictly about early stage
breast cancers - specifically those
that can still be treated with hormone
therapy, have not spread to the lymph
nodes and do not have the HER2
mutation, which makes them grow more quickly. The test is performed on
a sample of
the tumour when it is removed during
surgery. It works by looking at the activity
levels of 21 genes, which are markers
of how aggressive the cancer is.-BBC News
Comments
Post a Comment